Calumet, Inc. /DE (CLMT): what the price assumes
boothcheck covers Calumet, Inc. /DE (CLMT) but does not put one priced-in number on it: here the defensible answer is the evidence rather than a point estimate. boothcheck publishes no house fair value, target price, or buy/sell rating. Narrative composed 2026-07-25.
Generated: 2026-09-07 · Exported: 2026-09-09 · Source: https://boothcheck.com/report/CLMT
Headline
| Field | Value |
|---|---|
| Ticker | CLMT |
| Company | Calumet, Inc. /DE |
| Sector / Industry | Energy |
| Current price | $53.50/sh |
| Composition | Specialty Products and Solutions - Lubricating oils 18% / Specialty Products and Solutions - Solvents 10% / Specialty Products and Solutions - Waxes 4% / Specialty Products and Solutions - Fuels, asphalt and other by-products 32% / Montana/Renewables - Gasoline 3% / Montana/Renewables - Diesel 2% / Montana/Renewables - Jet fuel 0% / Montana/Renewables - Asphalt, heavy fuel oils and other 4% / Montana/Renewables - Renewable fuels 19% / Performance Brands 8% |
What The Price Assumes (Inversion)
The assumption today's price embeds, recovered by inverting the valuation.
| Field | Value |
|---|---|
| Inversion basis | whole-company |
| Multiple paid | 150x operating income |
How unusual the bet is: n/a
Valuation X-Ray
How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.
| Family | Median price/FV | Models | Reads |
|---|---|---|---|
| Asset | — | 0 | — |
| Earnings | — | 0 | — |
| Relative | — | 0 | — |
| Growth | — | 0 | — |
The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 6.8%); the inversion above states its own rate.
Per-Model Detail (n=1)
| Model | Family | FV | Price/FV | Applicable | Methodology |
|---|---|---|---|---|---|
| DCF Perpetual Growth | Growth | $0.14 | 382.14x | no | FCF base $0.0B, growth 13% (input: historical growth), terminal g 4.0%, WACC 6.8%, 5yr projection |
| DCF Exit Multiple | Growth | $60.73 | 0.88x | no | Exit EV/EBITDA: 24.9x / 29.9x / 34.9x (bear / base = today's held flat / bull), 5yr |
| Relative Valuation | Relative | — | — | no | P/S fallback (negative EPS): Sector P/S 1.2x × TTM revenue — excluded from consensus |
| Simple DDM | Growth | — | — | no | — |
| Two-Stage DDM | Growth | — | — | no | — |
| Simple Excess Return | Asset | — | — | no | — |
| Two-Stage Excess Return | Asset | — | — | no | — |
| Discounted Future Market Cap | Growth | $50.44 | 1.06x | no | Rev $4.6B, growth 13% (input: historical growth; tapered), Terminal P/S: 0.8x / 1.0x / 1.2x (bear / base = today's held flat / bull, cap 6x) |
| Peter Lynch Fair Value | Relative | $0.00 | — | no | Negative/zero EPS — earnings-based value floored at $0 |
| Margin Trajectory | Growth | — | — | no | — |
| Earnings Power Value | Earnings | — | — | no | — |
| Residual Income | Asset | — | — | no | — |
| Graham Number | Asset | — | — | no | — |
| EV/EBITDA Relative | Relative | — | — | no | EBITDA $0.23B × sector EV/EBITDA 6.0x |
| FCF Yield | Earnings | $0.01 | 5350.00x | yes | FCF $49.1M / Kₑ 9.3% — zero-growth perpetuity (excluded from median) |
| SBC-Adj FCF Yield | Earnings | — | — | no | — |
| Ben Graham Formula | Earnings | — | — | no | — |
| ROIC-Justified P/B | Asset | — | — | no | — |
| P/Sales Sector | Relative | — | — | no | Revenue $4.59B × sector P/S 1.2x |
| PEG Fair Value | Relative | — | — | no | — |
| Earnings Yield | Earnings | — | — | no | — |
| Funds From Operations Multiple | Relative | — | — | no | — |
| Clinical Phase NPV | Growth | — | — | no | — |
| Merton | Asset | — | — | no | — |
| V5 Mechanical | — | — | — | no | — |
Economic-Unit Decomposition (Sum Of The Parts)
One or more material disclosed units has unresolved economics. Unknown/general is not evidence of homogeneity: segment SOTP is primary but incomplete, consolidated cash flow may remain only a secondary cross-check when every unit shares an enterprise basis, and one sector multiple or target margin is withheld.
| Unit | Role | Valuation basis | Revenue | Reported profit | Value evidence | Status |
|---|---|---|---|---|---|---|
| Specialty Products and Solutions | operating | enterprise | $2.6b | — | withheld | unresolved no unit value |
| Performance Brands | operating | enterprise | $311.0m | — | withheld | unresolved no unit value |
| Montana/Renewables | operating | enterprise | $1.2b | — | withheld | unresolved no unit value |
No total common-equity value is stated. One or more material units lack a supported unit value. The displayed values are an indicative subtotal; consolidated debt and cash cannot be applied to a fraction of the company.
Solvency
| Field | Value |
|---|---|
| Net debt | $2.2b |
| Net debt / NOPAT (after-tax) | 57.80x |
| Net debt / operating income (pre-tax) | 45.66x |
| Interest coverage | 0.2x |
| Share count CAGR (dilution) | 3.2% |
| Burning cash | no |
Bullet Takeaways
- Two very different businesses share one ticker: a specialty hydrocarbon operation making lubricating oils, solvents, waxes and asphalt, where fuels, asphalt and other by-products is the single largest revenue line at about 32%, and Montana Renewables, a renewable fuels plant that contributes roughly a fifth of revenue and all of the story.
- The renewable half is being built with borrowed money that the parent does not stand behind: the FY2025 annual report records a "$1.44 billion guaranteed loan facility to fund the construction and expansion of the renewable fuels facility owned by MRL" and states that "Calumet is not a guarantor of MRL indebtedness."
- The first quarter of 2026 shows how little the headline tells you, with a reported net loss of $317.0 million that included $147.4 million of non-cash charges tied to renewable fuel credits and a further $102.7 million of unrealised derivative losses.
Bull Case
Refining is one of the few industries where a year of reported earnings tells you almost nothing about the business. Margins are the difference between two commodity prices neither party controls, inventories are marked through the income statement, and regulatory credits swing results by hundreds of millions without a dollar moving. Calumet takes that ordinary difficulty and adds a second layer, because half the company is not really a refinery at all. Specialty products such as lubricating oils, solvents and waxes are formulated, branded and sold into industrial supply chains on relationships rather than on the crack spread. The right way to read this company is as two asset bases with different economics, temporarily reported as one number.
The first quarter of 2026 makes the point with unusual clarity. The company reported a net loss of $317.0 million, and then explained that the figure contained $147.4 million of non-cash expense related to renewable fuel credits, $102.7 million of unrealised derivative losses, and $37.9 million of equity compensation expense that increased precisely because the share price went up. A loss driven partly by your own stock rising is a loss that is telling you about accounting, not operations. Underneath it, the specialty segment produced $44.3 million and the branded products segment $12.6 million on the company's own adjusted earnings measure.
That specialty half sits in niches the integrated majors treat as leftovers. The FY2025 annual report names the competition directly: "Our primary competitors in producing paraffinic lubricating oils include Exxon Mobil Corporation, Motiva Enterprises, LLC, Phillips 66, HF Sinclair Corporation and Chevron Corporation." Those are enormous companies for whom base oils and waxes are a small line item, which is exactly why a focused operator can hold share in them. The branded end of it, sold through Performance Brands, behaves differently again, and the first quarter carried record quarterly sales of the TruFuel line. Peers in that neighbourhood earn margins refining never sees: WDFC turns a 17.5% operating margin on $674.7 million of revenue, VVV 15.3% on $1.86 billion, CBT 15.7% on $3.58 billion. Refining peers live in a different band entirely, with DK at 2.3% on $10.73 billion and PBF at 2.5% on $30.17 billion. Calumet owns pieces of both worlds.
The renewables build is the reason the price is where it is, and its financing structure deserves attention. The annual report records that the company "executed a Loan Guarantee Agreement (the \"DOE Loan\") for a $1.44 billion guaranteed loan facility to fund the construction and expansion of the renewable fuels facility owned by MRL", with the first tranche of roughly $781.8 million already drawn, and adds that "MRL has the ability to draw additional tranches of up to $624.6 million through the anticipated completion of this project in 2028. Calumet is not a guarantor of MRL indebtedness." Read the last sentence twice. The expansion capital sits at the subsidiary, not on the parent's guarantee, which means the downside on the renewables bet is bounded in a way that a straight corporate borrowing would not be.
Two operational events since then matter more than the quarter they interrupted. Montana Renewables completed its turnaround and started up the MaxSAF 150 expansion in early May 2026, and the Shreveport plant, which lost roughly 750,000 barrels of production to organic chloride contamination in its crude supply, resumed normal operations in early April. Both drags were self-limiting. Management also described the regulatory backdrop as having shifted in its favour after the EPA announced its renewable volume obligations in March 2026. The bull case does not require the renewables plant to become a great business. It requires the specialty half to keep earning while the renewables half stops consuming, at which point the consolidated number starts describing the company again.
Bear Case
The uncomfortable thing about Calumet is not any single ratio. It is that a company carrying more debt than its entire specialty business is worth has been repriced as a growth story on the strength of a plant that is still being built. Everything else follows from that observation. The equity is the residual claim on a heavily levered, commodity-exposed asset base, and residual claims move violently in both directions for reasons that have very little to do with the operating business.
Start with what the balance sheet actually says. Book equity is negative, which is why most conventional valuation approaches decline to produce a number here at all. Net debt is roughly 2.2 billion dollars against gross borrowings a little higher, and the FY2025 annual report shows the cushion behind it shrinking: "The borrowing base on our revolving credit facilities decreased from approximately $472.1 million as of December 31, 2024, to approximately $412.3 million at December 31, 2025." The company is direct about what that implies, warning that "Our ability to service our indebtedness will depend upon, among other things, our future financial and operating performance, which will be affected by prevailing economic conditions and financial, business, regulatory and other factors, some of which are beyond our control." Trailing operating profit across the last twelve months came to almost nothing, which means the business is currently covering its interest bill out of timing and non-recurring items rather than out of operating earnings.
The renewables thesis rests on two things the company does not control, and it says so. The first is the price of sustainable aviation fuel, where the annual report lists among its risks the possibility that "SAF cannot generate the premium we currently expect, that a market for SAF does not evolve as expected and that alternate technologies supersede the expected demand for SAF". The second is the regulator. Renewable fuel economics run through volume obligations the EPA resets periodically, and the filing notes that "The periodic update process featured in the RFS and similar programs nonetheless introduces a degree of uncertainty in demand for our products on a yearly basis." A March 2026 announcement moved that setting in Calumet's favour. The same mechanism can move the other way, and it does not need a change of technology or a change of demand to do it, only a change of rule.
Operations have not been steady either. The first quarter lost roughly 750,000 barrels of production at Shreveport to contamination in the crude supply, and the renewables plant was down for a turnaround and expansion through March and into April. Neither event was strategic. Both are the kind of thing that happens to complex processing plants, which is precisely the risk in a business whose fixed charges do not pause when a unit does.
Against its cohort the profitability gap is stark. On trailing figures the consolidated operating margin rounds to essentially zero, which sits below even the refining comparison set, where DK runs 2.3% and CVI 2.2%, and far below the specialty and branded names Calumet's own segment mix invites comparison to, with CBT at 15.7% and IOSP at 6.9%. The bull answer is that the trailing figure is distorted, and it genuinely is. But a company that needs its reported numbers explained away for several consecutive periods is asking the market for patience that a levered balance sheet does not always allow. Share count has also crept up about 3.2% a year since late 2023, so the equity holder is funding some of that patience directly.
Valuation
Trailing profit is the wrong instrument for this company, and the reason is specific rather than an excuse. Operating profit across the last twelve months came to a rounding error on $4.17 billion of revenue, not because the business collapsed but because renewable fuel credit marks, derivative positions and inventory accounting run straight through the income statement in this industry. Divide any price by a number close to zero and the answer is arithmetic, not information. So the multiple that number produces is set aside here, and the assumption embedded in the price is treated as directional at best: the price leans on a long run of compounding that the current earnings base does not yet demonstrate.
That leaves the standard methods with very little to grip. Negative book equity removes the asset-value approaches. Negative trailing earnings and negative free cash flow remove the earnings-power and cash-flow approaches. What survives is a sales-based lens, and it says the price sits about a quarter below what a sector sales multiple applied to Calumet's revenue would imply. That comparison is worth exactly as much as its assumption, which is that a dollar of Calumet revenue deserves the same multiple as a dollar of the average energy company's revenue, and that the debt in front of the equity does not matter. Both are generous. The honest read of the method set is not that the price is defended. It is that the price is being set by something none of these frames measure.
What they do not measure is the renewables asset and the option attached to it. Montana Renewables commenced MaxSAF 150 operations in early May 2026 following its turnaround, and the expansion behind it is funded by a facility whose terms the annual report sets out plainly: "MRL has the ability to draw additional tranches of up to $624.6 million through the anticipated completion of this project in 2028. Calumet is not a guarantor of MRL indebtedness." That last clause is the single most important valuation fact in the filing, because it separates the parent's solvency from the project's outcome. The renewables bet can disappoint without dragging the specialty business into a restructuring.
Solvency is where the argument has to land, and here the picture is tight rather than dire. Net debt is roughly 2.2 billion dollars, cash on hand is thin, and the revolver's borrowing base fell over the course of 2025 to roughly $412.3 million. On the other side, the specialty and branded segments together produced $56.9 million on the company's own adjusted earnings measure in a quarter that included a major unplanned outage, and the renewables segment turned positive on that same measure once federal fuel credits are counted. The share count has grown about 3.2% a year since September 2023, which is modest for a company at this stage of a capital programme.
The decisive question is not what multiple to apply. It is whether the specialty business alone can carry the corporate debt while Montana Renewables is finished. If it can, the renewables plant is a free option on a fuel market the regulator has just made more attractive. If it cannot, the same option is being financed by the people who own the equity, one quarter at a time.
Catalysts
The first quarter of 2026 was a transitional quarter by design and by accident. Calumet reported a net loss of $317.0 million, or $3.64 per basic share, against a loss of $162.0 million, or $1.87 per share, a year earlier. The company attributed the widening to items that moved no money at all. Renewable fuel credits accounted for $147.4 million of expense, $102.7 million of unrealised derivative losses including $46.0 million tied to inventory inside its supply and offtake financing arrangement, and $37.9 million of equity compensation expense driven by the rise in its own share price. On the company's own adjusted earnings measure including federal tax attributes, the quarter produced $50.1 million against $55.0 million a year earlier.
Two operational disruptions sat inside those figures and have since cleared. The Shreveport facility took an unplanned outage after organic chloride contamination was discovered in its crude supply, costing roughly 750,000 barrels of production, and resumed normal operations in early April 2026. Montana Renewables entered a planned turnaround in March combined with the MaxSAF 150 expansion, and commenced operations on the expanded configuration in early May 2026. Renewable fuels production ran at 7,853 barrels per day in the quarter against 9,932 a year earlier, which is the turnaround showing up in the volume line rather than a demand problem.
The regulatory event is the one with the longest reach. Management described the EPA's renewable volume obligation announcement in March 2026 as having transformed the outlook for biofuel margins, and framed the company as entering a strong margin environment across both traditional and renewable markets. Separately, at the annual meeting on June 2, 2026 shareholders elected three Class II directors, approved executive compensation on an advisory basis, and ratified Grant Thornton LLP as auditor for the year ending December 31, 2026. What to watch from here is straightforward: whether the second-quarter print, with Shreveport running and Montana restarted, converts the improved margin backdrop into cash that reduces debt.
Peer Cohorts (Per Segment, With Filing Citations)
Specialty Products and Solutions (reported)
- KWR (QUAKER CHEMICAL CORPORATION)
- FY2025 10-K: …that we serve could have a material adverse effect on our liquidity, financial position and results of operations. As the leader in industrial process fluids, we are subject to the same business cycles as those experienced by our customers that participate in the steel, automotive, industrial equipment, aerospace,…
- FY2025 10-K: …customer could have a material adverse effect on our business. 7 We may not be able to timely develop, manufacture and gain market acceptance of new and enhanced products required to maintain or expand our business, which could adversely affect our competitive position and our liquidity, financial position and…
- VVV (VALVOLINE INC.)
- FY2025 10-K: …To both acquire and retain customers, marketing plays an important role in demonstrating the distinct experience that Valvoline offers customers, as well as providing information on locations, promotions, services offered, and wait times. Techniques utilized by the Company are intended to build awareness of and…
- FY2025 10-K: , Valvoline and the Company's franchise partners simplify vehicle care so customers can do what drives them. This includes approximately 15-minute stay-in-your-car oil changes; battery, bulb and wiper replacements; tire rotations; and other manufacturer recommended maintenance services. For over 15 decades, Valvoline…
- NGVT (INGEVITY CORPORATION)
- FY2025 10-K: …in gasoline vapor emission control systems in internal combustion engines and hybrid electric vehicles including cars, trucks, motorcycles, and boats. We also produce several other activated carbon products for food, water, beverage, and chemical purification applications. Our Performance Chemicals segment products…
- FY2025 10-K: …and consistent profitability: Performance Materials and Pavement Technologies. New Ingevity's businesses will be focused on high-value, mission-critical applications that benefit from durable, long-term demand and will allow Ingevity to retain our global scale, maintain a strong pro forma financial profile, and…
- IOSP (INNOSPEC INC.)
- FY2025 10-K: …of specialty chemicals markets, we also supply niche product lines, where we enjoy market-leading positions. Fuel Specialties: The Fuel Specialties segment is generally characterized by a small number of competitors, none of which hold a dominant position. We consider our competitive edge to be our proven technical…
- FY2025 10-K: …The segment has grown organically through our development of new products to address increased demand for fuel, focus on fuel economy, compatibility of renewable fuels, higher efficiency engine technologies and legislative developments, including tightening global emissions regulations. We are also 2 applying these…
- CBT (Cabot Corporation)
- FY2025 10-K: …sale of specialty carbons and products for battery materials applications with a mix of global and regional companies. In recent years, a number of these companies that operate regionally have increased the export of products outside their region of manufacture. For fumed alumina, we compete primarily with one…
- FY2025 10-K: …conductive additives and other materials for battery applications, and inkjet dispersions for high-speed industrial printing applications, including packaging and graphic arts. The recent investments we have made for growth in this segment, including with respect to these specific areas of focus, are described below…
Performance Brands (reported)
- VVV (VALVOLINE INC.)
- FY2025 10-K: …To both acquire and retain customers, marketing plays an important role in demonstrating the distinct experience that Valvoline offers customers, as well as providing information on locations, promotions, services offered, and wait times. Techniques utilized by the Company are intended to build awareness of and…
- FY2025 10-K: …the most likely amount method that is expected to be earned as the Company is able to estimate the anticipated discounts within a sufficiently narrow range of possible outcomes based on its extensive historical experience with certain customers and similar programs. Variable consideration is reassessed at each…
- WDFC (WD-40 COMPANY)
- FY2025 10-K: …We are a meritocracy with a competitive performance-based total rewards strategy, where compensation and career advancement are determined by demonstrated competencies and contributions. Our calendar year 2023 global pay equity study reaffirmed there were not statistically significant or systemic gender-based pay…
- FY2025 10-K: Current trends among these large retailers include increased demand for new innovative products and marketing, requiring suppliers to maintain or reduce product prices and to deliver products within shorter lead times. Our products compete both within their own product classes as well as within product distribution…
- KWR (QUAKER CHEMICAL CORPORATION)
- FY2025 10-K: …performance obligation. In accordance with the last step of the five-step model, the Company recognizes revenue when, or as, it satisfies the performance obligation in a contract by transferring control of a promised good or providing the service to the customer. The Company typically satisfies its performance…
- FY2025 10-K: …customers. To do this, the Company applies a five-step model, which requires the Company to: (i) identify the contract with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract;…
Montana/Renewables (reported)
- DK (DELEK US HOLDINGS, INC.)
- FY2025 10-K: …or acquired environmental credits meeting our recognition criteria in excess of our current environmental credits obligation (a "surplus"). Any obligation would be measured at fair value either directly through the observable inputs or indirectly through the market-corroborated inputs. The net cost of environmental…
- FY2025 10-K: …Inc., Delek Holdco, Inc., Dione Mergeco, Inc., Astro Mergeco, Inc. and Alon USA Energy, Inc. (incorporated by reference to Exhibit 2.1 to the Company's Form 8-K filed on January 3, 2017). 2.2 First Amendment to Agreement and Plan of Merger dated as of February 27, 2017, among Delek US Holdings, Inc., Delek Holdco,…
- CVI (CVR ENERGY, INC)
- FY2025 10-K: …seasonal increases in highway traffic and road construction work. Demand for diesel fuel is higher during the planting and harvesting seasons. As a result, our results of operations for the Petroleum Segment for the first and fourth calendar quarters are generally lower compared to our results for the second and…
- FY2025 10-K: …cvi:RenewablesDieselMember cvi:RenewablesSegmentMember 2024-01-01 2024-12-31 0001376139 us-gaap:OperatingSegmentsMember cvi:RenewablesDieselMember cvi:RenewablesSegmentMember 2023-01-01 2023-12-31 0001376139 us-gaap:OperatingSegmentsMember cvi:RenewableFuelCreditsMember cvi:RenewablesSegmentMember 2025-01-01…
- PBF (PBF ENERGY INC.)
- FY2025 10-K: …within the refining, mid-stream and renewable diesel or alternative energy sectors based on performance through the cycle, advantageous access to crude oil supplies, attractive refined products market fundamentals and access to distribution and logistics infrastructure. For example, we are a key participant of the…
- FY2025 10-K: …of existing rules, may necessitate additional expenditures in future years. The Company is required to comply with the RFS. Pursuant to the Energy Policy Act of 2005 and the Energy Independence and Security Act of 2007, the EPA has issued the RFS, implementing mandates to blend renewable fuels into the petroleum…
- VLO (VALERO ENERGY CORP/TX)
- FY2025 10-K: …those sales. Clean fuel production credits that have not been sold on behalf of the other joint venture member as of the balance sheet date are reflected in prepaid expenses and other. Clean fuel production credits that are expected to be sold are recorded at fair value based on the expected sales price. See Note 19…
- FY2025 10-K: …vlo:FutureMaturityNextFiscalYearMember us-gaap:PublicUtilitiesInventoryPetroleumProductsMember us-gaap:CashFlowHedgingMember 2025-01-01 2025-12-31 0001035002 vlo:FutureMaturityNextFiscalYearMember us-gaap:NotDesignatedAsHedgingInstrumentEconomicHedgeMember vlo:CrudeOilAndRefinedPetroleumProductsMember…
Methodology Note
- Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
- Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
- Economic-unit decomposition (SOTP): each disclosed business unit is assigned its native valuation basis before any multiple is applied. Operating units are valued on enterprise value; funded financial units are valued on their own common equity, because their borrowings fund earning assets rather than levering the parent. A company total is stated only once every material unit carries a supported value and the parent capital bridge reconciles.
- Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
- Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.
Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.
Sources
Calumet first-quarter 2026 results, 8-K filed May 8, 2026 · Calumet 8-K filed June 3, 2026